Individual Variation and the Acceptance of Average Bioequivalence
نویسندگان
چکیده
Regulatory criteria established for the acceptance of average bioequivalence do not fully satisfy the requirements arising for the interchangeability of drug products. The divergence is illustrated by noting that the regulatory criteria are compatible with large inter-individual variation of within-subject differences or ratios of the relevant kinetic parameters. Regulatory criteria of three jurisdictions are considered: the United States, Canada, and the Province of Ontario. For example, in a crossover trial conducted with 24 subjects, in as many as 60% of the individuals, the difference between the relevant kinetic parameters for the two formations could, on average, be outside the range of 70-130% of the reference product, and still satisfy the criterion of the Food and Drug Administration (FDA) for the acceptance of average bioequivalence. It is suggested that individual bioequivalence can be effectively evaluated in threeand four-way crossover trials.
منابع مشابه
Bioequivalence Study of Two Formulations of Tramadol Capsules in Healthy Myanmar Volunteers
Background: Tramadol is one of the most commonly used analgesics, thanks to its efficacy and safety. It is widely used in Myanmar for postoperative and cancer pain control. The use of generic drugs has been steadily increasing worldwide, mostly in developing countries. Generic drugs should have efficacy and safety comparable to their innovators or other approved generic products. Objectives: ...
متن کاملAnalysis of a 3-period 2-treatment pharmacokinetic study to assess scaled average bioequivalence
In the past years various approaches for assessing bioequivalence of so-called "highly variable drugs" have been debated. These are drugs whose pharmacokinetic profiles vary considerably when given to the same subject. As a consequence of the high variability, average bioequivalence between two such drugs can only be shown with an unfeasibly high number of subjects. Therefore regulatory agencie...
متن کاملBioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial
BACKGROUND Although the generic drug approval process has a long-term successful track record, concerns remain for approval of narrow therapeutic index generic immunosuppressants, such as tacrolimus, in transplant recipients. Several professional transplant societies and publications have generated skepticism of the generic approval process. Three major areas of concern are that the pharmacokin...
متن کاملImplementation of a reference-scaled average bioequivalence approach for highly variable generic drug products of agomelatine in Chinese subjects
The aim of this study was to apply the reference-scaled average bioequivalence (RSABE) approach to evaluate the bioequivalence of 2 formulations of agomelatine, and to investigate the pharmacokinetic properties of agomelatine in Chinese healthy male subjects. This was performed in a single-dose, randomized-sequence, open-label, four-way crossover study with a one-day washout period between dose...
متن کاملEffect of Replicate Design on Drug Variability and Bioequivalence in Humans
The purpose of this study is to investigate the effect of using replicate design on the intra/inter subject variability and bioequivalence of drugs in healthy volunteers. Model drugs used for analysis were amoxicillin/clavulanic acid combination. 24 healthy subjects participated in this study using 4-phase replicate cross over design. Individual disposition kinetic parameters of areas under pla...
متن کامل